Compare ARK Genomic Revolution ETF (ARKG) vs Williams Companies Inc (WMB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Williams Companies Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Williams Companies Inc trades at $75.28 (market cap $91.75B). The key difference: Williams Companies Inc pays a 2.8% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | WMB | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $79.40 |
52-Week Low | $23.09 | $56.51 |
Market Cap | — | $91.75B |
Enterprise Value | — | $121.14B |
Dividend Yield | — | 2.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Williams Companies (WMB) trades at $75.02, down 0.57% on the day, with strong analyst consensus (79% buy ratings) and a $85.58 price target suggesting 14% upside. The stock shows bullish technical signals with moving averages supporting upward momentum, while fundamentals reveal robust profitability (23.4% net margin) and positive cash flow trends. Recent news highlights WMB's potential $5.5 billion acquisition of Momentum Midstream to expand natural gas infrastructure.
WMB presents a compelling investment case with stable fee-based revenue, dividend growth potential, and strategic expansion plans. Key risks include execution of large acquisitions, commodity price volatility exposure, and high debt levels. The current valuation at 32.9x P/E appears elevated but justified by strong earnings growth and sector-leading margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
